Evidence of neurophysiological improvement of early manifestations of small-fiber dysfunction after liver transplantation in a patient with familial amyloid neuropathy

[1]  D. Adams,et al.  Familial amyloid polyneuropathy , 2017, Current opinion in neurology.

[2]  C. Lacroix,et al.  Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment? , 2016, Revue neurologique.

[3]  A. Nakae,et al.  Normative data for A&dgr; contact heat evoked potentials in adult population: a multicenter study , 2016, Pain.

[4]  R. Labaudinière,et al.  Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis , 2016, Neurology and Therapy.

[5]  N. Heaton,et al.  Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? , 2015, Transplantation.

[6]  M. Benson,et al.  A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis , 2015, Neurology and Therapy.

[7]  Whei-Min Lin,et al.  Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates , 2015, Annals of neurology.

[8]  M. Carvalho,et al.  Neurophysiological techniques to detect early small‐fiber dysfunction in transthyretin amyloid polyneuropathy , 2014, Muscle & nerve.

[9]  P. Schestatsky,et al.  Disturbed sensory perception of changes in thermoalgesic stimuli in patients with small fiber neuropathies , 2013, PAIN®.

[10]  R. Labaudinière,et al.  Tafamidis for transthyretin familial amyloid polyneuropathy , 2012, Neurology.

[11]  M. Munar-Qués,et al.  Early diagnosis and management of patients with familial ATTR amyloidosis receiving livers from asymptomatic variant TTR carriers , 2011, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[12]  P. Low,et al.  Patterns of neuropathy and autonomic failure in patients with amyloidosis. , 2008, Mayo Clinic proceedings.

[13]  E. Granieri,et al.  The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology , 2008, Brain : a journal of neurology.

[14]  M. Carvalho,et al.  Neurophysiological markers in familial amyloid polyneuropathy patients: Early changes , 2008, Clinical Neurophysiology.

[15]  M. Solé,et al.  Finding of vascular amyloid TTR in inferior nasal concha in a patient with FAP TTRVal30Met , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[16]  M. de Carvalho,et al.  Clinical variability in type I familial amyloid polyneuropathy (Val30Met): Comparison between late‐ and early‐onset cases in Portugal , 2007, Muscle & nerve.

[17]  M. de Carvalho,et al.  Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M) , 2002, Amyloid: Journal of Protein Folding Disorders.

[18]  S. Metral,et al.  The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. , 2000, Brain : a journal of neurology.

[19]  F. Salvi,et al.  Electromyographic findings in transthyretin (TTR)-related familial amyloid polyneuropathy (FAP). , 1996, Electroencephalography and clinical neurophysiology.

[20]  David Bruce Lewis,et al.  Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation , 1996, Neurology.

[21]  M. Saadeh,et al.  Liver , 2016, Laboratory Investigation.